Viridian Therapeutics, Inc. (VRDN)
NASDAQ·Healthcare·Biotechnology
$13.64
+1.04%
Mkt Cap $1.22B
Analyst Ratings
Buy
17
Hold
2
Sell
0
Price Target (30 analysts)
$43.10
Range $34.00 – $50.00
Implied Upside
+216.0%
Consensus $43.10 vs current $13.64
NASDAQ·Healthcare·Biotechnology
$13.64
+1.04%
Mkt Cap $1.22B
Buy
17
Hold
2
Sell
0
Price Target (30 analysts)
$43.10
Range $34.00 – $50.00
+216.0%
Consensus $43.10 vs current $13.64